N. Tohse et al., CYCLIC GMP-MEDIATED INHIBITION OF L-TYPE CA2-CELLS( CHANNEL ACTIVITY BY HUMAN NATRIURETIC PEPTIDE IN RABBIT HEART), British Journal of Pharmacology, 114(5), 1995, pp. 1076-1082
1 Effects of atrial natriuretic peptide (ANP) on the L-type Ca2+ chann
els were examined in rabbit isolated ventricular cells by use of whole
-cell and cell-attached configurations of the patch clamp methods. ANP
produced a concentration-dependent decrease (10-100 nM) in amplitude
of a basal Ca2+ channel current.2 The inactive ANP (methionine-oxidize
d ANP, 30 nM) failed to decrease the current. 3 8-Bromo-cyclic GMP (30
0 mu M), a potent activator of cyclic GMP-dependent protein kinase (PK
G), produced the same effects on the basal Ca2+ channel current as tho
se produced by ANP. The cyclic GMP-induced inhibition of the Ca2+ chan
nel current was still evoked in the presence of 1-isobutyl-3-methyl-xa
nthine, an inhibitor of phosphodiesterase. ANP failed to produce inhib
ition of the Ca2+ channel current in the presence of 8-bromo-cyclic GM
P. 4 In the single channel recording, ANP and 8-bromo-cyclic GMP also
inhibited the activities of the L-type Ca2+ channels. Both agents decr
eased the open probability (NP0) without affecting the unit amplitude.
5 The present results suggest that ANP inhibits the cardiac L-type Ca
2+ channel activity through the intracellular production of cyclic GMP
and then activation of PKG.